Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A plus triple combination cream versus triple combination cream alone for melasma
TCTR20240721002Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of incobotulinumtoxinA, fluocinolone acetonide + hydroquinone + tretinoin in melasma, sponsored by Mahidol University. Started Aug 2023; status: completed.
02
Drugs
incobotulinumtoxinAfluocinolone acetonide + hydroquinone + tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20240721002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240721002.